Volume : 11, Issue : 10, October – 2024
Title:
NANO CARRIERS IN CANCER THERAPY: CHALLENGES AND OPPORTUNITIES
Authors :
Bhakti Malve*, Vishal Rasve*, Gaffer Sayeed, Sanjay Garje
Abstract :
Nanocarriers have emerged as a promising approach in cancer therapy, offering innovative solutions to overcome the limitations of traditional treatments such as chemotherapy and radiation. By enhancing drug delivery and targeting capabilities, nanocarriers, including liposomes, dendrimers, nanoparticles, and micelles, provide a platform for the controlled and sustained release of anticancer drugs. This review explores the various types of nanocarriers, their mechanisms of action, and how they improve the pharmacokinetics and bioavailability of therapeutic agents. Key challenges such as drug resistance, toxicity, and the complexity of tumor environments are also discussed, along with the opportunities nanocarriers present in personalized cancer therapy. Furthermore, recent advancements in nanotechnology, including active targeting strategies, combination therapies, and multifunctional nanocarriers, are examined. Despite the significant potential of nanocarriers in cancer treatment, ongoing research is required to address regulatory hurdles, large-scale production issues, and patient-specific responses. This review emphasizes the crucial role of nanocarriers in the future of oncology, highlighting the opportunities they provide for more effective and less toxic cancer treatments.
KEYWORDS: Nanocarriers, cancer therapy, drug delivery, nanoparticles, liposomes, personalized medicine, tumor targeting, chemotherapy, nanotechnology, oncology.
Cite This Article:
Please cite this article in press Bhakti Malve et al., Nano Carriers In Cancer Therapy: Challenges And Opportunities..,Indo Am. J. P. Sci, 2024; 11 (10).
Number of Downloads : 10
References:
1. Jain KK. Nanomedicine: Applications of nanobiotechnology in medical science. Expert Rev Med Devices. 2005;2(2):205-17.
2. Peer D, Kimmelman J, Lander E, Drapkin R. Nanotechnology and cancer: The promise and challenge of the new era. Nat Rev Cancer. 2007;7(1):65-70.
3. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Advanced Drug Delivery Reviews. 2013;65(1):36-48.
4. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185-98.
5. Khan Y, Rani N, Ranjan K, et al. Nanoparticles in cancer therapy: a comprehensive review. Pharmaceutics. 2021;13(9):1343.
6. Chen Y, Du J, Liu Y, et al. Biodegradable polymeric nanoparticles for drug delivery in cancer therapy. Adv Drug Deliv Rev. 2015;90:44-59.
7. Sweeney EE, Zhang X, Zhang Q, et al. Dendrimers for cancer therapy: An overview. Bioconjug Chem. 2018;29(5):1341-56.
8. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161-77.
9. Kwon GS, Park K. Superporous hydrogel: A new approach to drug delivery systems. J Control Release. 2013;170(3):283-91.
10. Dykman LA, Khlebtsov NG. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev. 2012;41(6):2256-82.
11. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun. 2005;(5):571-7.
12. Tseng CL, Wu YR, Wang YY, et al. The EPR effect: Mechanisms and strategies for cancer therapy. J Biomed Sci. 2020;27(1):56.
13. Ameen D, Alafnan A, Alkhateeb A. Emerging nanotechnology and its applications in cancer therapy. Eur J Pharmacol. 2019;860:172551.
14. Saha S, Kaur P, Kaur S, et al. Nanotechnology-based approaches for targeted cancer therapy: A review. Nanomedicine. 2020;15(12):1213-27.
15. van der Meel R, Fens MH, de Smet M, et al. Cancer nanomedicine: The importance of the tumor microenvironment. Nano Today. 2014;9(6):726-35.
16. Poon Z, Kingston BR, Chen C, et al. Engineering nanoparticles to improve drug delivery: From empirical to engineered systems. Small. 2014;10(14):2759-78.
17. Kivimäe S, Aavik E, Tamm A, et al. Nanoparticle-based drug delivery systems for the treatment of cancer. Expert Opin Drug Deliv. 2016;13(2):263-75.
18. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991-1003.
19. Barenholz Y. Doxil® – the first FDA-approved nano-drug: Lessons learned. Nat Rev Drug Discov. 2012;9(1):51-7.
20. Dhanikula AB, Vangala A, Bansal D, et al. Development of polymeric nanoparticles for drug delivery in cancer therapy. Int J Nanomedicine. 2019;14:7853-71.
21. Xu M, Zhang Y, Zhang R, et al. Nanotechnology in cancer therapy: Overcoming the barriers of drug delivery and bioavailability. Expert Opin Drug Deliv. 2020;17(7):965-79.
22. Dube A, Rujanavech C, Wong D. A review of recent advancements in the development of nanocarrier-based cancer therapeutics. Nanotechnology. 2021;32(34):342001.
23. Zhang X, Wu Y, Gao S, et al. Smart nanocarriers for drug delivery: The role of pH and temperature sensitivity. Int J Pharm. 2021;605:120749.
24. Zhang Y, Liu R, Liu Y, et al. Recent advances in cancer therapy using nanocarrier systems: An overview. J Control Release. 2021;330:308-24.
25. Kim Y, Park K. Strategies for improving the delivery of drugs using nanocarriers in cancer therapy. Chem Eng Sci. 2017;169:221-34.
26. Salatin S, Mohammadi S, Ghasemi Y, et al. Liposomes and their applications in cancer therapy. Drug Deliv. 2021;28(1):530-50.
27. Jain S, Jain A, Jain SK. Polymeric nanoparticles: A review on formulation and its applications in drug delivery. Indian J Pharm Sci. 2021;83(1):1-8.
28. Ameer F, Maras J, Khabarova M, et al. Dendrimers as multifunctional nanocarriers in cancer therapy. Front Chem. 2021;9:628116.
29. Dastan D, Zare A, Parivar K, et al. Solid lipid nanoparticles for drug delivery: A review of recent advancements. Front Pharmacol. 2021;12:634506.
30. Barenholz Y. Doxil®—the first FDA-approved nano-drug: Lessons learned. Nat Rev Drug Discov. 2012;9(1):51-7.
31. Poon Z, Kingston BR, Chen C, et al. Engineering nanoparticles to improve drug delivery: From empirical to engineered systems. Small. 2014;10(14):2759-78.
32. Xiong W, Zhao J, Liu S, et al. The role of nanocarriers in cancer therapy: A comprehensive review. Adv Drug Deliv Rev. 2021;171:1-15.
33. Zhao Y, Zhang Y, Hu Q, et al. Targeted drug delivery in cancer therapy with nanoparticle-based systems. Nanomedicine. 2021;16(19):1549-72.
34. Zhao J, Feng S, Wu Y, et al. Polymeric micelles: A promising drug delivery system for cancer therapy. Int J Pharm. 2021;607:120878.
35. Jang E, Yoon S, Choi D, et al. Nanoparticle-based drug delivery systems for cancer therapy: Progress and challenges. Pharmaceutics. 2020;12(10):934.
36. Cheng Y, Hu Y, Liu X, et al. The role of nanoparticles in cancer therapy: a review. Int J Nanomedicine. 2021;16:2143-67.
37. Yang Y, Wang Z, Zhang Q, et al. Applications of nanotechnology in cancer therapy: From drug delivery to diagnosis. Biomed Mater. 2021;16(6):62004.
38. Li Y, Huang Y, Zhang S, et al. Recent advances in polymeric nanocarriers for cancer therapy. Asian J Pharm Sci. 2021;16(1):1-19.
39. Liu Y, Ma D, Zhang H, et al. Applications of carbon-based nanomaterials in cancer therapy: A review. Curr Cancer Drug Targets. 2021;21(3):236-54.
40. Sharma A, Kaur R, Kaur T, et al. Recent advances in the design and development of polymeric nanoparticles for cancer therapy. J Drug Deliv Sci Technol. 2021;61:102193.
41. Chen L, Chen D, Zhou Y, et al. Advances in theranostics with multifunctional nanocarriers in cancer therapy. J Nanobiotechnol. 2021;19(1):1-17.
42. Choi HS, Liu W, Liu F, et al. Design considerations for nanoparticles in drug delivery. Nat Rev Drug Discov. 2013;12(5):339-52.
43. Cheetham SW, Tilley RD, Prakash G, et al. Challenges and advances in the synthesis of drug-loaded nanoparticles. J Control Release. 2019;310:152-73.
44. Dhanikula AB, Vangala A, Bansal D, et al. Development of polymeric nanoparticles for drug delivery in cancer therapy. Int J Nanomedicine. 2019;14:7853-71.
45. Khaing ZZ, Bogart LK, Tran S, et al. Nanoparticle design and applications in cancer therapy. J Control Release. 2021;330:1002-21.
46. Banerjee S, Ghosh R, Mukherjee S, et al. Nanotechnology in cancer therapy: A review of recent advances. Nanomedicine. 2020;15(8):1213-34.
47. Yadav A, Gupta A, Tripathi A, et al. Nanotechnology for cancer treatment: An overview of therapeutic approaches and their effectiveness. J Drug Deliv Sci Technol. 2020;57:101725.
48. Li M, Huang C, Yang Y, et al. Applications of nanomaterials in cancer therapy and their challenges. Nanomaterials. 2021;11(1):63.
49. He C, Zhang Z, Hu Y, et al. Cancer nanomedicine: Overcoming the barriers to cancer therapy. Biomaterials. 2016;82:97-107.
50. Roy S, Awasthi V, Bansal D, et al. Cancer nanotechnology: Current applications and future perspectives. Biomed Pharmacother. 2021;143:112175.